Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 248 participants.
Also called NCT04195568
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 248 participants
- Sponsor
- Registry
-
NCT04195568
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States, Australia, Canada
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04195568. Allocation not applicable; no masking; primary purpose treatment. Start 2020-07-07 (actual); primary completion 2025-07-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System
- Acronym
- EVOLVE
- Condition
- Aneurysm, Intracranial
- Intervention (Device)
- Surpass Evolve Flow Diverter System
- Lead sponsor
- Stryker Neurovascular
Record details
- Record id
cardio:ct-nct04195568- Content hash
4e19da9ecd3cffb7a8a95f8d0143353ee91a4ef3eafcae2b4452c80adb42279d